The Role and Mechanism of O-GlcNAc Glycosylation Modified HAS2 in the Hyaluronic Acid Synthesis in ARDS
Sponsor: Southeast University, China
Listed as NCT05055557, this observational or N/A phase trial focuses on Hyaluronic Acid and remains ongoing. Sponsored by Southeast University, China, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Dec 2021 — Oct 2023 [monthly]
Not Yet Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Southeast University, China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.